1-1 of 1
Matthew A Huggins
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti CD161 Antibody IMT-009 Is a Novel Immunotherapeutic Agent That Effectively Blocks the Inhibitory CLEC2D/CD161 Axis in CLEC2D+ B Cell Hematological Malignancies Reinvigorating T and NK Cell Function Leading to Anti-Tumor Benefit

Matthew Bernstein, Elizabeth Scanlon, Alexandria Fusco, Frano Irvine, Flavian D Brown, Jeffrey D Colbert, Matthew A Huggins, Michael Ross, Ming Tang, Shruti Malu
Journal: Blood
Blood (2023) 142 (Supplement 1): 2815.
https://doi.org/10.1182/blood-2023-190957
Published: 2023